Mechanism of Class II Correction With Fixed Lingual Mandibular Growth Modificator (FLMGM)
NCT ID: NCT01853995
Last Updated: 2014-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
43 participants
INTERVENTIONAL
2009-05-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The null hypothesis stated that there were no significant differences in dentoskeletal changes between FLMGM treated group and control untreated group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fixed Lingual Mandibular Growth Modificator
NCT01853137
Treatment of Class III Malocclusion Using Modified Fixed Mandibular Retractor Appliance
NCT03354442
Evaluation of Pain and Functional Impairments When Treating Class III Malocclusion Using Two Treatment Procedures
NCT06877780
Mini-implant-supported Twin-Block in Treating Patients With Class II Division 1 Malocclusion
NCT06403033
Treating Growing Patients With Mandibular Prognathism and Maxillary Constriction
NCT06762418
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Of the 43 patients initially enrolled, 38 completed this trial and comprised the final sample, and 5 (4 treated, 1 untreated) were excluded.
The final sample comprised 38 subjects who completed this trial. All patients and parents gave prior informed consent to their inclusion in the investigation.
Patients of both groups were followed on a parallel basis during a period of 8 months and the trial included all patients regardless of achievement of a Class I incisor relationship. All patient of treatment group (n=21) were treated using FLMGM without extractions or any other form of orthodontic treatment, though the treatment was continued beyond this time point if the Class II malocclusion was not fully corrected and clinical objectives were not achieved. On the other hand, no orthodontic treatment was performed during that duration for the subjects of control group (n=17), and most of control subjects were offered suitable treatment at a later date.
For each patient, a direct digital lateral cephalogram was taken pre- and post- treatment/observation using PAX 400 (VATECH CO., Korea) with the same settings. All cephalograms were digitized on screen by a cursor-driven mouse and analyzed in a blind manner by the same orthodontist using a commercial cephalometric software (Viewbox, version 3.1.1.13, dHAL Software, Kifissia , Hellas, Greece). All measurements were reduced to life size (radiographic enlargement of 7.54 % in the median plane).
At the end of the treatment/observation period, sagittal occlusal (SO) analysis, according to the method of Pancherz modified by Franchi et al, was applied to assess sagittal occlusal changes and identify the mechanism of Class II correction. Moreover, the total mandibular length (Condyle-Gnathion) was measured.
The sample was used as a whole and not differentiated by sex. Pretreatment equivalence and comparison of changes observed in the FLMGM and control groups were tested for significance with independent-sample t-test using SPSS, version 16.0. Changes occurring during the examination period in each group were tested with paired-sample t-test. P values of less than 0.05 were considered statistically significant.
To assess the method error, twenty cephalograms were picked at random from the treatment and control groups and redigitized and analyzed by the same orthodontist after an interval of 1 month, and the combined error of cephalometric method was calculated by Dahlberg's formula.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FLMGM Treatment Group
Cl II/1 patients treated with Fixed Lingual Mandibular Growth Modificator (FLMGM)
Fixed Lingual Mandibular Growth Modificator (FLMGM)
New Class II Corrector
Untreated Class II Control Group
control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fixed Lingual Mandibular Growth Modificator (FLMGM)
New Class II Corrector
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mild to moderate Class II Skeletal pattern (A-N-B \> 4°) with retrognathic mandible (S-N-B \< 76°).
* Growth potential. Fishman skeletal maturation indicator (SMI) method was used to assess the hand-wrist radiographs, and only patients in the peak of the pubertal growth spurt, which occurs on average between SMIs 4 to 7, at the beginning of the treatment/observation period were invited.
Exclusion Criteria
* clinically obvious facial asymmetry
* extreme vertical disproportion
* prior orthodontic therapy
* permanent tooth extractions
* significant medical history
11 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Damascus University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Osama AlAli
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Osama H Alali, PhD
Role: PRINCIPAL_INVESTIGATOR
Senior Lecturer, Department of Orthodontics, School of Dentistry, University of Aleppo, Syria
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Orthodontics, School of Dentistry, University of Damascus
Damascus, Rif-dimashq Governorate, Syria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FLMGM: Mechanism of Correction
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.